학술논문
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
Document Type
Article
Author
Thiele, E.A.; Marsh, E.D.; French, J.A.; Mazurkiewicz, M.B.; Benbadis, S.R.; Joshi, C.; Lyons, P.D.; Taylor, A.; Roberts, C.; Sommerville, K.; Gunning, B.; Gawlowicz, J.; Lisewski, P.; Mitosek Szewczyk, K.; Steinborn, B.; Zolnowska, M.; Hughes, E.; McLellan, A.; Benbadis, S.; Ciliberto, M.; Clark, G.; Dlugos, D.; Filloux, F.; Flamini, R.; French, J.; Frost, M.; Haut, S.; Joshi, C.; Kapoor, S.; Kessler, S.; Laux, L.; Lyons, P.; Marsh, E.; Moore, D.; Morse, R.; Nagaraddi, V.; Rosenfeld, W.; Seltzer, L.; Shellhaas, R.; Thiele, E.; Thio, L.L.; Wang, D.; Wilfong, A.
Source
In: The Lancet . (The Lancet, 1 January 2018, 391(10125):1085-1096)
Subject
Language
English
ISSN
1474547X
01406736
01406736